O'Connor B J, Lecomte J M, Barnes P J
Department of Thoracic Medicine, National Heart and Lung Institute, Royal Brompton Hospital, London.
Br J Clin Pharmacol. 1993 Jan;35(1):55-7. doi: 10.1111/j.1365-2125.1993.tb05671.x.
Histamine H3-receptor agonists inhibit excitatory neuro-transmission in human and guinea-pig airways. Since neural bronchoconstriction may be important in asthma we have studied the effect of a specific H3-receptor agonist R-alpha-methylhistamine (alpha MeHA) on bronchoconstriction induced by the inhaled irritant sodium metabisulphite (MBS) in six mild asthmatic subjects in a randomised double-blind crossover study. Subjects received either alpha MeHA, 10 mg (as a chloride salt) or matched placebo (P) and were then challenged with doubling concentrations of MBS (0.3-80 mg ml-1) nebulised from a dosimeter at 5 min intervals with measurement of specific airway conductance (sGaw) and FEV1 at 2 and 4 min respectively after each inhalation. There was no effect of alpha MeHA on baseline airway calibre and the log concentrations of MBS required to lower sGaw by 50% (log PC50) and FEV1 by 20% (log PC20) were not significantly different after alpha MeHA when compared with placebo, suggesting that selective stimulation of airway H3-receptors does not inhibit MBS-induced bronchoconstriction.
组胺H3受体激动剂可抑制人和豚鼠气道中的兴奋性神经传递。由于神经源性支气管收缩在哮喘中可能起重要作用,我们在一项随机双盲交叉研究中,研究了特异性H3受体激动剂R-α-甲基组胺(αMeHA)对6名轻度哮喘患者吸入刺激性物质焦亚硫酸钠(MBS)所诱发的支气管收缩的影响。受试者分别接受10mg(作为氯盐)的αMeHA或匹配的安慰剂(P),然后每隔5分钟用剂量仪雾化递增浓度的MBS(0.3 - 80mg/ml)进行激发试验,每次吸入后分别在2分钟和4分钟测量比气道传导率(sGaw)和第1秒用力呼气量(FEV1)。αMeHA对基线气道管径无影响,与安慰剂相比,αMeHA给药后使sGaw降低50%所需的MBS对数浓度(log PC50)和使FEV1降低20%所需的MBS对数浓度(log PC20)无显著差异,这表明气道H3受体的选择性刺激并不能抑制MBS诱发的支气管收缩。